Financhill
Back

Lexaria Bioscience Stock Predictions

Lexaria Bioscience Stock Forecast

  • Is Lexaria Bioscience Stock Undervalued?
    The current Lexaria Bioscience [LEXX] share price is $2.20. The Score for LEXX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • LEXX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Lexaria Bioscience Stock Go Up Next Year?

Data Unavailable

Lexaria Bioscience Stock Rating

Data Unavailable

Lexaria Bioscience Stock Price History

Is LEXX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lexariabioscience.com

52-Week Data

52-Week High:
6.85
52-Week Low:
1.20

Prediction Charts

Market Cap:
34.78M
Price in USD:
2.20
Volume:
96.89K
Beta:
1.24

Technical Analysis

SMA50:
2.78
SMA100:
2.97
SMA200:
3.03
52-Wk Change:
78.86%

Stock Predictions

  • Is Lexaria Bioscience stock public?
    Yes, Lexaria Bioscience is a publicly traded company.
  • What is the Lexaria Bioscience stock quote today?
    The Lexaria Bioscience stock price is 2.20 USD today.
  • How to buy Lexaria Bioscience stock online?
    You can buy Lexaria Bioscience shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 2.16 2.32 2.38 2.16
Nov-4 2.33 2.28 2.46 2.22
Nov-5 2.26 2.23 2.31 2.16
Nov-6 2.25 2.19 2.25 2.17
Nov-7 2.22 2.32 2.35 2.18
Nov-8 2.36 2.36 2.42 2.25
Nov-11 2.40 2.31 2.40 2.22
Nov-12 2.32 2.30 2.34 2.20
Nov-13 2.34 2.25 2.42 2.22
Nov-14 2.28 2.12 2.32 2.10
Nov-15 2.12 2.01 2.14 1.95
Nov-18 2.03 2.09 2.12 1.97
Nov-19 2.08 2.17 2.20 2.02
Nov-20 2.19 2.20 2.28 2.16

Lexaria Bioscience Earnings

Data Unavailable

Lexaria Bioscience Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.

* Lexaria Bioscience stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.